VITREOUS LOSS

This adverse event was reported 62 times

VITREOUS LOSS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BALANCED SALT SOLUTION 5 0.0039
1 VERTEPORFIN FOR INJECTION 2 0.0014
2 FLUOCINOLONE ACETONIDE 2 0.0005
3 TRANDOLAPRIL TABLETS 1 0.0005
4 HYPROMELLOSE 1 0.0004
5 SULINDAC 1 0.0004
6 DIPYRIDAMOLE 1 0.0003
7 DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE 2 0.0003
8 BRIMONIDINE TARTRATE, TIMOLOL MALEATE 1 0.0002
9 DORZOLAMIDE 1 0.0001
See all drugs enriched for association with VITREOUS LOSS

VITREOUS LOSS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Photoenhancer [EPC] 2 0.0005
1 Prostaglandin Analog [EPC] 4 0.0000
2 Vascular Endothelial Growth Factor Inhibitor [EPC] 4 0.0000
3 Folate Analog [EPC] 1 0.0000
4 Vitamin A [EPC] 1 0.0000
5 5-alpha Reductase Inhibitor [EPC] 2 0.0000
6 Nicotinic Acid [EPC] 1 0.0000
7 Antidote [EPC] 1 0.0000
8 Angiotensin Converting Enzyme Inhibitor [EPC] 2 0.0000
9 Corticosteroid [EPC] 17 0.0000
See all drug classes enriched for association with VITREOUS LOSS